bay x 1005 has been researched along with cp 547632 in 1 studies
| Studies (bay x 1005) | Trials (bay x 1005) | Recent Studies (post-2010) (bay x 1005) | Studies (cp 547632) | Trials (cp 547632) | Recent Studies (post-2010) (cp 547632) |
|---|---|---|---|---|---|
| 58 | 6 | 8 | 19 | 1 | 13 |
| Protein | Taxonomy | bay x 1005 (IC50) | cp 547632 (IC50) |
|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0093 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0715 | |
| Angiopoietin-1 receptor | Homo sapiens (human) | 0.319 | |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | 0.237 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for bay x 1005 and cp 547632
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |